UBS lowered the firm’s price target on Centene (CNC) to $42 from $43 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
 
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Centene price target raised to $45 from $43 at Oppenheimer
 - Centene’s Uncertain Future: Sell Rating Amid Medicaid and Exchange Challenges
 - Centene Corporation Reports Q3 2025 Financial Results
 - Centene’s Earnings Call: Positive Outlook Amid Challenges
 - Morning Movers: Nvidia jumps after GTC, Trump comments
 
